Holen Sie sich die Stockscreener-App
20.23
5.07%
-1.08
Vorhandelsmarkt:
19.94
-0.29
-1.43%
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences (WVE) CFO Moran sells shares worth $4.1 million - Investing.com India
Verdine of Wave Life Sciences sells shares worth $269k - Investing.com India
Wave Life Sciences director Wagner sells $189,000 in shares - Investing.com India
Corrigan sells Wave Life Sciences (WVE) shares worth $217k - Investing.com India
Wave Life Sciences director Henry sells shares for $1.36 million - Investing.com India
Tan Aik Na of Wave Life Sciences sells $1.82 million in stock - Investing.com
Wave Life Sciences exec Francis sells $6.4m in shares - Investing.com
Wave Life Sciences director Rawcliffe sells $630k in shares - Investing.com
Insider Sell: Mark Corrigan Sells Shares of WAVE Life Sciences L - GuruFocus
Golden Cross Alert: 3 Stocks With Major Upside Potential - MarketBeat
Is It Too Late To Buy WVE Shares? - timothysykes.com
Wave Life Science prices upsized $350M stock ofeering - MSN
Wave Life Sciences (WVE) Stock Drops Significantly by 9.7% - GuruFocus
Wave Life Sciences stock falls after announcing $350 million public offering - Investing.com
Wave Life Sciences: 200% Rally On 1% Weight Loss Feels Bloated (NASDAQ:WVE) - Seeking Alpha
Wave Life Sciences (WVE) Upsizes Public Offering to Raise $350 M - GuruFocus
Wave Life Sciences (WVE) Announces Upsized $350M Public Offering - GuruFocus
Wave Life Sciences falls after pricing $350 mln stock offering - TradingView
Why Wave Life Sciences Stock Crushed it Again Today - sharewise.com
Wave Life Sciences Prices Upsized $350 Million Public Offering - marketscreener.com
WVE Stock Offering Expanded and Priced Under Market Value - GuruFocus
Wave Life Sciences prices public offering at $19 per share - Investing.com
Wave Life Sciences Prices $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - Quiver Quantitative
Wave Life Sciences (Nasdaq: WVE) prices $350M share and pre-funded warrant sale - Stock Titan
Wave Life Sciences prices upsized $350 million offering at a price of $19 per share - marketscreener.com
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times
Wave Life Sciences Prices Upsized $350 Million Offering At A Price of $19 Per Share - TradingView
Why Wave Life Sciences Stock Crushed it Again Today - The Motley Fool
Wave Life Sciences: Stock Skyrockets on Positive Phase 1 Clinical Trial Results - StocksToTrade
WVE: Citigroup Raises Price Target for WAVE Life Sciences to $30 | WVE Stock News - GuruFocus
WVE: Canaccord Genuity Raises WAVE Life Sciences Price Target to $40 | WVE Stock News - GuruFocus
Wave Life Sciences (WVE) Soars to 6-Year High on Obesity Drug Clinical Trial - Insider Monkey
What's Going On With Wave Life Sciences Stock Tuesday? - Benzinga
WVE: Wells Fargo Raises Price Target with Overweight Rating | WV - GuruFocus
Wave Surges As Obesity Candidate Cuts Fat And Spares Muscle - Citeline News & Insights
Why Wave Life Sciences (WVE) Is Up 164.9% After Obesity RNA Data And $250 Million Raise - Yahoo Finance
Wave Life Sciences (WVE) Upgraded to Outperform on Promising Obe - GuruFocus
Wave Life Sciences upgraded at RBC following data for obesity asset WVE-007 (WVE:NASDAQ) - Seeking Alpha
RBC Capital Upgrades Wave Life Sciences (WVE) - Nasdaq
Wave Life Sciences Stock Surges Amid Promising Trial Data - timothysykes.com
Wave Life Sciences (WVE): Revisiting Valuation After a 39% YTD Surge and 3-Year Share Price Tripling - simplywall.st
Cantor Fitzgerald Raises Price Target for WVE to $34.00 | WVE St - GuruFocus
WAVE Life Sciences (NASDAQ:WVE) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active - Markets Financial Content
WVE: Clear Street Raises Price Target and Maintains Buy Rating | WVE Stock News - GuruFocus
RBC Capital Upgrades WVE with a 200% Price Target Increase | WVE Stock News - GuruFocus
WAVE Life Sciences stock price target raised to $40 from $19 at Canaccord - Investing.com
JPMorgan Chase & Co. Boosts Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
Raymond James raises WAVE Life Sciences stock price target to $21 on obesity drug data - Investing.com
WAVE Life Sciences (NASDAQ:WVE) Sets New 52-Week HighHere's Why - MarketBeat
Wave Life Sciences (WVE) Stock Reaches 52-Week High on Positive Obesity Trial Data - CoinCentral
WAVE Life Sciences (NASDAQ:WVE) Nasdaq Composite ETF Biotech Trends - Kalkine Media
RBC Capital upgrades WAVE Life Sciences stock to Outperform on obesity drug data - Investing.com Australia
Why Wave Life Sciences Stock Vaulted 146% Higher on Monday - sharewise.com
Wave Life Sciences Rides Positive Data To Big Stock Gains - Finimize
Wave Life Sciences Soars 147% on Breakthrough “Targeted Fat Loss” Drug Data - NAI500
Nvidia, AMD, Wave Life Sciences, Toll Brothers And Carvana: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Wave Life Sciences (WVE) Soars 147% on Obesity Drug Breakthrough and $250M Offering: What to Know Before the December 9 Open - ts2.tech
Wave Life Sciences announces $250M public offering and pre-funded warrants - MSN
Wave (WVE) Shows Promising Phase 1 Results in Obesity Study - GuruFocus
Wave Life Sciences Ltd. (WVE): A Bull Case Theory - Insider Monkey
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):